Altered cholecystokinin binding site density in the supraoptic nucleus of morphine-tolerant and -dependent rats

Brain Research

Volumn 780, Issue 2, 1998, Pages 190-198

  Munro, Gordon ^a   Pumford, Kathryn M ^a   Russell, John A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Opiate tolerance; Oxytocin; PreproCCK mRNA expression; Salt loading

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; FEMALE; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SUPRAOPTIC NUCLEUS;

EID: 0032509736     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01137-2     Document Type: Article

References (47)

1. Bicknell R.J., Leng G., Lincoln D.W., Russell J.A. Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment. J. Physiol. 396:1988;297-317.
2. Bouman H.J., Van Wimersma Greidanus T.J.B. Rapid and simple cannulation technique for repeated sampling of cerebrospinal fluid in freely moving rats. Brain Res. Bull. 4:1979;575-577.
3. Bourque C.W., Oliet S.H.R., Kirkpatrick K., Richard D., Fisher T.E. Extrinsic and intrinsic mechanisms involved in regulating the activity of supraoptic neurones. Ann. NY Acad. Sci. 689:1993;512-519.
4. Brimble M.J., Dyball R.E.J. Characterisation of the responses of oxytocin and vasopressin secreting neurones in the supraoptic nucleus to osmotic stimulation. J. Physiol. 271:1977;253-371.
5. Brown C.H., Munro G., Murphy N.P., Leng G., Russell J.A. Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine-dependence or withdrawal excitation. J. Physiol. 496:1996;787-794.
6. 28,31)-CCK 25-33S. Eur. J. Neurosci. 4:1992;563-573.
7. Christie M.J., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance: Studies in single brain neurons. Mol. Pharmacol. 32:1987;633-638.
8. Day N.C., Hall M.D., Hughes J. Modulation of hypothalamic cholecystokinin receptor density with changes in magnocellular activity: a quantitative autoradiographic study. Neuroscience. 29:1989;371-383.
9. Deschenes R.J., Lorenz L.J., Haun R.S., Roos B.A., Collier K.J., Dixon J.E. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc. Natl. Acad. Sci. USA. 81:1984;726-730.
10. Deschepper C., Lostra F., Vandesande F., Vanderhaeghen J.-J. Cholecystokinin varies in the posterior pituitary and external median eminence of the rat according to factors affecting vasopressin and oxytocin. Life Sci. 32:1983;2572-2577.
11. Dietl M.M., Palacios J.M. The distribution of cholecystokinin receptors in the vertebrate brain: Species differences studied by receptor autoradiography. J. Chem. Neuroanat. 2:1989;149-161.
12. Dourish C.T., O'Neill M.F., Coughlan J., Kitchener S., Hawley D., Iversen S.D. The selective CCK-B antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 176:1990;35-44.
13. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.L. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
14. Hinks G.L., Poat J.A., Hughes J. The effect of salt-loading on CCK receptors. Soc. Neurosci. Abstr. 19:1993;67.
15. B receptors in the rat brain. Mol. Cell. Neurosci. 4:1993;143-154.
16. Ingram S.M., Krause R.G., Baldino F. Jr., Skeen L.C., Lewis M.E. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. J. Comp. Neurol. 287:1989;260-272.
17. Jarvis C.R., Bourque C.W., Renaud L.P. Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro. J. Physiol. 458:1992;621-632.
18. Kennedy C., Henderson G. μ-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells following chronic exposure to morphine in vitro. Mol. Pharmacol. 40:1991;1000-1005.
19. Luckman S.M., Antonijevic I., Leng G., Dye S., Douglas A.J., Russell J.A., Bicknell R.J. The maintenance of normal parturition in the rat requires neurohypophysial oxytocin. J. Neuroendocrinol. 5:1993;7-12.
20. Ludwig M., Johnstone L.E., Neumann I., Landgraf R., Russell J.A. Direct hyperosmotic stimulation of the rat supraoptic nucleus increases c-fos gene expression in glial cells rather than magnocellular neurones. Cell Tissue Res. 287:1997;79-90.
21. 5-enkephalin, and cholecystokinin-like substances. Neuroscience. 8:1983;213-227.
22. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
23. Meister B., Broberger C., Villar M.J., Hökfelt T. Cholecystokinin B receptor gene expression in hypothalamic neurosecretory neurons after experimental manipulations. Neuroendocrinology. 60:1994;458-469.
24. Meister B., Villar M.J., Ceccatelli S., Hökfelt T. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: An immunohistochemical study using experimental manipulations. Neuroscience. 37:1990;603-633.
25. Moran T.H., Robinson P.H., Goldrich M.S., McHugh P. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362:1986;175-179.
26. Munro G., Pumford K.M., Russell J.A. Morphine tolerance/dependence increases cholecystokinin (CCK) binding in the rat supraoptic nucleus (SON). Br. J. Pharmacol. 109S:1993;102.
27. Neumann I., Landgraf R., Takahashi Y., Pittmann Q.J., Russell J.A. Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8. Am. J. Physiol. 267:1994;R1626-R1631.
28. Neumann I., Russell J.A., Landgraf R. Oxytocin and vasopressin release within the supraoptic nuclei of pregnant, parturient and lactating rats: a microdialysis study. Neuroscience. 53:1993;65-75.
29. Oliet S.H.R., Bourque C.W. Mechanosensitive channels transduce osmosensitivity in supraoptic neurones. Nature. 364:1993;341-343.
30. Onaka T., Luckman S.M., Antonijevic I., Palmer J.R., Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience. 66:1995;403-412.
31. Onaka T., Luckman S.M., Guevara-Guzman R., Ueta Y., Kendrick K., Leng G. Presynaptic actions of morphine: blockade of cholecystokinin-induced noradrenaline release and Fos expression in the rat supraoptic nucleus. J. Physiol. 482:1995;69-79.
32. O' Shea R.D., Gundlach A.L. Regulation of cholecystokinin receptors in the hypothalamus of the rat: reciprocal changes in magnocellular nuclei induced by food deprivation and dehydration. J. Neuroendocrinol. 5:1993;697-704.
33. G. Paxinos, C. Watson, (Eds.), The Rat Brain in Stereotaxic Coordinates, Academic Press, London, 1982.
34. Pumford K.M., Leng G., Russell J.A. Morphine actions on supraoptic neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion. J. Physiol. 440:1991;437-454.
35. Pumford K.M., Russell J.A., Leng G. Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats. Exp. Brain Res. 94:1993;237-246.
36. Rayner V.C., Robinson I.C.A.F., Russell J.A. Chronic intracerebroventricular morphine and lactation in rats: dependence and tolerance in relation to oxytocin neurones. J. Physiol. 396:1988;319-347.
37. Rhodes C.H., Morrell J.I., Pfaff D.W. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin and vasopressin. J. Comp. Neurol. 198:1981;45-64.
38. Russell J.A., Coombes J.E., Leng G., Bicknell R.J. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis. J. Physiol. 469:1993;365-386.
39. Russell J.A., Leng G., Bicknell R.J. Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism? Exp. Physiol. 80:1995;307-340.
40. Stanfa L., Dickenson A., Xu X.-J., Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Neurosci. 15:1994;65-66.
41. Sumner B.E.H., Coombes J.E., Pumford K.M., Russell J.A. Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats. Neuroscience. 37:1990;635-645.
42. J.J. Vanderhaeghen, S.N. Schiffman, Distribution of brain neuronal CCK, in: C.T. Dourish, S.J. Cooper, S.D. Iversen, L.L. Iversen (Eds.), Multiple Cholecystokinin Receptors in the CNS, Oxford Univ. Press, New York, 1992, pp. 39-56.
43. Wakerley J.B., Noble R., Clarke G. Effects of morphine and D-Ala, D-Leu enkephalin on the electrical activity of supraoptic neurosecretory cells in vitro. Neuroscience. 10:1983;73-81.
44. Wakerley J.B., Poulain D.A., Brown D. Comparison of firing patterns in oxytocin and vasopressin-releasing neurones during progressive dehydration. Brain Res. 148:1978;425-440.
45. Wang X.-J., Han J.-S. Modification by cholecystokinin octapeptide of the binding of μ-, δ-, and κ-opioid receptors. J. Neurochem. 55:1990;1379-1382.
46. Wank S.A., Harkins R., Jensen R.T., Shapira H., de Weerth A., Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. USA. 89:1992;3125-3129.
47. Wank S.A., Pisegna J.R., de Weerth A. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. USA. 89:1992;8691-8695.